In addition to IL-17 and IL-22 antibodies, APECED patients demonstrated autoantibodies specific for IL-6, whereas IL-23 autoantibodies were present in approximately 27.9% of thymoma patients but not in APECED patients [63]. This evidence concerns the gene IL17A and thymoma.